MaxCyte, Inc. (MXCT) stock
MXCTNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3065% below fair value
$1.10−0.03 (-2.65%)
Close on Nov 11, 2026Market cap $113.53MP/E –Yield –
MaxCyte cash
Cash and short-term investments held at the end of each period.
MaxCyte's cash was $101.28M at Sep 30, 2026. For fiscal 2025 it was $103.04M, down 33.3% from the year before. The highest annual figure on record is $255.04M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $103.04M | -33.3% |
| FY2024 | Dec 31, 2024 | $154.48M | -8.2% |
| FY2023 | Dec 31, 2023 | $168.29M | -26.0% |
| FY2022 | Dec 31, 2022 | $227.34M | -10.9% |
| FY2021 | Dec 31, 2021 | $255.04M | +633.7% |
| FY2020 | Dec 31, 2020 | $34.76M | +128.5% |
| FY2019 | Dec 31, 2019 | $15.21M | +35.2% |
| FY2018 | Dec 31, 2018 | $11.25M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $101.28M | -4.2% |
| Q2 FY2026 | Jun 30, 2026 | $105.69M | -16.5% |
| Q1 FY2026 | Mar 31, 2026 | $106.85M | -22.7% |
| Q4 FY2025 | Dec 31, 2025 | $103.04M | -33.3% |
| Q3 FY2025 | Sep 30, 2025 | $105.73M | -31.3% |
| Q2 FY2025 | Jun 30, 2025 | $126.56M | -19.6% |
| Q1 FY2025 | Mar 31, 2025 | $138.27M | -12.2% |
| Q4 FY2024 | Dec 31, 2024 | $154.48M | -8.2% |
| Q3 FY2024 | Sep 30, 2024 | $153.83M | -19.1% |
| Q2 FY2024 | Jun 30, 2024 | $157.33M | -27.2% |
| Q1 FY2024 | Mar 31, 2024 | $157.51M | -29.9% |
| Q4 FY2023 | Dec 31, 2023 | $168.29M | -26.0% |
| Q3 FY2023 | Sep 30, 2023 | $190.24M | -18.3% |
| Q2 FY2023 | Jun 30, 2023 | $216.11M | -10.3% |
| Q1 FY2023 | Mar 31, 2023 | $224.65M | -8.8% |
| Q4 FY2022 | Dec 31, 2022 | $227.34M | -10.9% |
| Q3 FY2022 | Sep 30, 2022 | $232.89M | -9.0% |
| Q2 FY2022 | Jun 30, 2022 | $240.89M | +228.2% |
| Q1 FY2022 | Mar 31, 2022 | $246.28M | +212.9% |
| Q4 FY2021 | Dec 31, 2021 | $255.04M | +633.7% |
| Q3 FY2021 | Sep 30, 2021 | $255.89M | +1121.3% |
| Q2 FY2021 | Jun 30, 2021 | $73.39M | +92.3% |
| Q1 FY2021 | Mar 31, 2021 | $78.70M | +417.4% |
| Q4 FY2020 | Dec 31, 2020 | $34.76M | +209.1% |
| Q3 FY2020 | Sep 30, 2020 | $20.95M | – |
| Q2 FY2020 | Jun 30, 2020 | $38.17M | – |
| Q4 FY2019 | Dec 31, 2019 | $15.21M | – |
| Q4 FY2018 | Dec 31, 2018 | $11.25M | – |
See a number that looks wrong?